MDS | Tumor

CURE’s myelodysplastic syndrome (MDS) page is an extensive resource of cancer information featuring the latest myelodysplastic syndrome news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on MDS.

FDA Approves Tool for Blood Cancer Detection

June 30th 2017, 5:51pm

Article

ClearLLab multicolor reagents (T1, T2, B1, B2, M) gained approval from the Food and Drug Administration (FDA) to detect chronic leukemia, acute leukemia, non-Hodgkin lymphoma, multiple myeloma, myelodysplastic syndrome (MDS) and myeloproliferative neoplasms (MPN). This is the first approval the agency received for immunophenotyping on a flow cytometer.

The Wonder of the Oncology Nurse

May 31st 2017, 5:40am

Article

What do oncology nurses mean to their patients? This is an inside view from one grateful patient.

Being Vulnerable With Cancer Is OK

February 7th 2017, 9:51pm

Article

Exploring a Promising Option for Low-Risk MDS

December 22nd 2016, 9:04pm

Article

Revlimid is showing promise for patients with low-risk MDS, according to the results of a recent study.

Higher Cost Does Not Improve Overall Survival in Elderly Patients with MDS

May 24th 2016, 9:07pm

Article

High cost does not always mean better chances of survival for elderly patients with MDS, according to a recent study.

Jason R. Gotlib on JAK Inhibitors for the Treatment of Myelofibrosis

March 23rd 2016, 12:48am

Video

Jason R. Gotlib discusses JAK inhibitors for the treatment of patients with myelofibrosis.

Making the Connections: My Nurse's Proactive Approach to Treatment

February 17th 2016, 2:34am

Article

An essay honoring Emily A. Knight, RN, OCN [Mayo Clinic Cancer Center in Scottsdale, Arizona]

Rebecca N. Claassen on the Importance of Educating Nurses About MPNs

December 21st 2015, 4:01pm

Video

Rebecca N. Claassen discusses the importance of educating nurses about myeloproliferative neoplasms (MPNs).

Susan Melvin Hill on Supporting MPN Patients in Idaho

December 21st 2015, 3:59pm

Video

Susan Melvin Hill, patient advocate, discusses how she meets with and helps patients with myeloproliferative neoplasms (MPNs) in Idaho.

Personalizing Treatment From Start to Finish in Polycythemia Vera

November 11th 2015, 8:36pm

Article

Ruben A. Mesa addressed the current treatment landscape for PV last week at the 33rd Annual Chemotherapy Foundation Symposium, a meeting of over 1,000 physicians and other oncology professionals.